First AD

Second AD

FLEX Trial: Genomic Testing of HER2 Status in ER+/HER2-Breast Cancer

Insights

Insights is an expert interview video series of leading oncologists that provides in-depth reports and feature segments profiling leaders in a range of oncology disciplines, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, gynecologic cancers, and hematologic malignancies. Most episodes feature 2 clinicians discussing the latest oncology advances in clinical practice. 

Breast Cancer

ELI-22-OSD1261 - /clinical/colorectal-cancer

 Breast Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of breast cancer, including those that are triple negative, hormone receptor positive, and/or HER2 positive. This page features news articles, interviews in written and video format, and podcasts that focus on treatment advances and ongoing research in breast cancer.

Insights Video Series

Genomic Testing for Improved Treatments in Breast Cancer

Expert oncologists discuss genomic testing for patients with HER2-low breast cancer, noting the FLEX trial of MammaPrint and BluePrint.

Evolving Treatment Paradigms for Early-Stage Breast Cancers

Overview of Genomic Assays for Early-Stage Breast Cancer

MammaPrint: A 70-Gene Signature Test for Patient with Breast Cancer

Clinical Considerations of Genomic Testing in Early-Stage Breast Cancer

Exploring Multigene Genomic Assays in High-Risk BC Patients

Real-World Evidence in Genomic Testing from SABCS 2023

Racial Disparities and Genomic Testing for Breast Cancer Patients

Reflecting on Genomic Testing in Practice for Breast Cancer

Ongoing Studies in Genomic Testing for Breast Cancer